Skip to main content
Livermore
Livermore
ZHEN

ING Groep NV

SEC CIK
0001039765
Latest filing
Aug 13, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by ING Groep NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
8,686
Value
$3.12M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of WST by ING Groep NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,686$3.12M<0.1%+8,686NewHolders
Q1 20260$00.0%−14,853−100.0%Sold outHolders
Q4 202514,853$4.09M<0.1%−17,581−54.2%ReducedHolders
Q3 202532,434$8.51M<0.1%−5,557−14.6%ReducedHolders
Q2 202537,991$8.31M0.1%+35,805+1,637.9%AddedHolders
Q1 20252,186$489.4K<0.1%−2,857−56.7%ReducedHolders
Q4 20245,043$1.65M<0.1%−1,169−18.8%ReducedHolders
Q3 20246,212$1.86M<0.1%−19,390−75.7%ReducedHolders
Q2 202425,602$8.43M0.1%+25,602NewHolders
Q1 20240$00.0%−10,129−100.0%Sold outHolders
Q4 202310,129$3.57M<0.1%+556+5.8%AddedHolders
Q3 20239,573$3.59M<0.1%−1,033−9.7%ReducedHolders
Q2 202310,606$4.06M<0.1%+9,926+1,459.7%AddedHolders
Q1 2023680$235.6K<0.1%−11,907−94.6%ReducedHolders
Q4 202212,587$2.96M<0.1%+981+8.5%AddedHolders
Q3 202211,606$2.86M<0.1%−2,334−16.7%ReducedHolders
Q2 202213,940$4.21M<0.1%+2,187+18.6%AddedHolders
Q1 202211,753$4.83M<0.1%+2,084+21.6%AddedHolders
Q4 20219,669$4.54M<0.1%+3,458+55.7%AddedHolders
Q3 20216,211$2.64M<0.1%+148+2.4%AddedHolders
Q2 20216,063$2.18M<0.1%+5,157+569.2%AddedHolders
Q1 2021906$255.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.